Medications for the treatment, induction of remission, and maintenance of ulcerative colitis.
ACR/ARHP Annual Meeting 2015
Ustekinumab (UST) benefits patients with psoriatic arthritis (PsA) with spondylitis and peripheral joint involvement, according to an post-hoc analysis of results from the PSUMMIT 1 & 2 phase 3 double-blind, placebo-controlled clinical trials, reported at the 2015 ACR/ARHP Annual Meeting.
Currently, COPD guidelines recommend that patients with acute exacerbations be treated with systemic corticosteroids for 7-14 days, however, an updated review suggests that corticosteroid treatment of a shorter duration may be as effective as conventional longer-duration therapy.
The recommendations for asthma management during pregnancy and lactation are presented in this table.
The Global Initiative for Asthma (GINA)'s 2012 Guidelines provides a stepwise plan for treatment of asthma, based on disease severity.
The most recent guidelines from the American College of Rheumatology
include pharmacologic and nonpharmacologic therapy for hyperuricemia.
Drugs in the Pipeline
Merck announced data for its investigational Timothy grass sublingual allergy immunotherapy tablet (MK-7243) to treat the underlying cause of allergic rhinitis.
Children and adolescents who are obese are more likely to develop severe forms of asthma.
The FDA has approved Simponi (golimumab for subcutaneous injection; Janssen Biotech) to induce and maintain clinical response in adults with ulcerative colitis.
Inhalation doses for the treatment of asthma and prevention of exercise induced bronchospasm (EIB).